[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@Bbrc424864Bbrc](/creator/twitter/Bbrc424864Bbrc) "$ESPR The triple combo patent was recently approved in Japan. If Otsuka wants to license this product they will likely pay between $XX million and $XX million depending on deal scope and exclusivity. If Daiichi Europe wants the triple combo and they do want it expect them to pay $XX million to $XX million depending on deal scope and timing. These are the upfront payments. Contracts likely include royalties just like the current contracts for Nexletol and Nexlizet" [X Link](https://x.com/Bbrc424864Bbrc/status/1977590133042872592) [@Bbrc424864Bbrc](/creator/x/Bbrc424864Bbrc) 2025-10-13T04:20Z XXX followers, XXX engagements "@msp12389 Then they need a CMO Or can they outsource those duties to Evotec" [X Link](https://x.com/Bbrc424864Bbrc/status/1978896450303013031) [@Bbrc424864Bbrc](/creator/x/Bbrc424864Bbrc) 2025-10-16T18:50Z XXX followers, XXX engagements "$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes" [X Link](https://x.com/Bbrc424864Bbrc/status/1979272042513142204) [@Bbrc424864Bbrc](/creator/x/Bbrc424864Bbrc) 2025-10-17T19:43Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Bbrc424864Bbrc
"$ESPR The triple combo patent was recently approved in Japan. If Otsuka wants to license this product they will likely pay between $XX million and $XX million depending on deal scope and exclusivity. If Daiichi Europe wants the triple combo and they do want it expect them to pay $XX million to $XX million depending on deal scope and timing. These are the upfront payments. Contracts likely include royalties just like the current contracts for Nexletol and Nexlizet"
X Link @Bbrc424864Bbrc 2025-10-13T04:20Z XXX followers, XXX engagements
"@msp12389 Then they need a CMO Or can they outsource those duties to Evotec"
X Link @Bbrc424864Bbrc 2025-10-16T18:50Z XXX followers, XXX engagements
"$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes"
X Link @Bbrc424864Bbrc 2025-10-17T19:43Z XXX followers, XXX engagements
/creator/twitter::1948622330743476225/posts